logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Sung Yong Oh

Dong-A University
H指数:42
被引数:8,545

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

套细胞淋巴瘤巩固治疗的治疗演变及对生存的影响：来自亚太地区真实世界登记研究的见解

Blood Cancer Journal
IF11.6
2026-05-290
OAAI
Hyungwoo Cho; Koji Kato; Jason Yongsheng Chan; Kim Dajung; Haiwen Huang; Qingqing Cai; Tongyu Lin; Udomsak Bunworasate; Sen-Mui Tan; Ka-Won Kang; Jae-Yong Kwak; Tsai-Yun Chen; Jeong-Ok Lee; Seong Hyun Jeong; Young Rok Do; Esther Chan; Hye Jin Kang; Hyeon-Seok Eom; Sung Yong Oh; Youngil Koh; Hyo Jung Kim; Se-Hyung Kim; Jong Ho Won; Young Hoon Park; Deok Hwan Yang; Soo Chin Ng; Jae-Cheol Jo; Hilman Tadjoedin; Anna Mira Lubis; Noorwati Sutandyo; Tsuyoshi Muta; Ken Takase; Dok Hyun Yoon; Won Seog Kim
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial (vol 6, pg 528, 2025)

奥德诺奈特单抗单药治疗复发/难治性弥漫性大B细胞淋巴瘤：ELM-2试验第二阶段（vol 6, pg 528, 2025）的主要有效性和安全性分析

NATURE CANCER
IF28.5
2025-04-160
OA
Kim, Won Seog; Kim, Tae Min; Cho, Seok-Goo; Jarque, Isidro; Iskierka-Jazdzewska, Elzbieta; Poon, Li Mei; Prince, H. Miles; Zhang, Huilai; Cao, Junning; Zhang, Mingzhi; Tessoulin, Benoit; Oh, Sung Yong; Lim, Francesca; Carpio, Cecilia; Tan, Tran-Der; Ayyappan, Sabarish; Gutierrez, Antonio; Cai, Jingxian; Ufkin, Melanie; Shariff, Saleem; Brouwer-Visser, Jurriaan; Chaudhry, Aafia; Mohamed, Hesham; Ambati, Srikanth; Walewski, Jan
Efficacy of combined CD38 and PD-1 inhibition with isatuximab and cemiplimab for relapsed/refractory NK/T-cell lymphoma

CD38和PD-1联合抑制（使用isatuximab和cemiplimab）对复发/难治性NK/T细胞淋巴瘤的疗效

Blood
IF23.1
2025-03-130
PRE
Seok Jin Kim; Jing Quan Lim; Sang Eun Yoon; Deok-Hwan Yang; Ji Hyun Lee; Sung Yong Oh; Yoon Seok Choi; Seong Hyun Jeong; Min Kyoung Kim; Sung Nam Lim; Junhun Cho; Bon Park; Kyung Ju Ryu; Seunghyun Choi; Yoon Park; Kerry May Huifen Lim; Nur Ayuni Binte Muhammad Taib; Choon Kiat Ong; Soon Thye Lim; Won Seog Kim
Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study

靶向CD19近膜域的新型anti-CD19嵌合抗原受体T细胞产品对非霍奇金淋巴瘤的安全性和有效性: 一项首次人体研究

MOLECULAR CANCER
IF33.9
2023-12-098
OAAI
Zhang, Yunlin; Patel, Ruchi P.; Kim, Ki Hyun; Cho, Hyungwoo; Jo, Jae-Cheol; Jeong, Seong Hyun; Oh, Sung Yong; Choi, Yoon Seok; Kim, Sung Hyun; Lee, Ji Hyun; Angelos, Mathew; Guruprasad, Puneeth; Cohen, Ivan; Ugwuanyi, Ositadimma; Lee, Yong Gu; Pajarillo, Raymone; Cho, Jong Hyun; Carturan, Alberto; Paruzzo, Luca; Ghilardi, Guido; Wang, Michael; Kim, Soohwan; Kim, Sung-Min; Lee, Hyun-Jong; Park, Ji-Ho; Cui, Leiguang; Lee, Tae Bum; Hwang, In-Sik; Lee, Young-Ha; Lee, Yong-Jun; Porazzi, Patrizia; Liu, Dongfang; Lee, Yoon; Kim, Jong-Hoon; Lee, Jong-Seo; Yoon, Dok Hyun; Chung, Junho; Ruella, Marco
Pexa-vec (thymidine kinase-deactivated vaccinia virus plus GM-CSF) in combination with cemiplimab (REGN2810; ANTIPD-1) for metastatic or unresectable renal cell carcinoma REN026: Results from a phase II study
ANNALS OF ONCOLOGY
IF65.4
2023-10-011
OAAI
Rha, S. Y.; Bae, W. K.; Kim, C.; Oh, S. Y.; Lee, H. W.; Park, K.; Mar, N.; Kichenadasse, G.; Ha, H. K.; Pachynski, R.; Park, I.; Park, K. H.; Kim, S. H.; Folefac, E.; Mathias, M. D.; Seebach, F.; Ma, S.; Carranza, L.; Beom, S-H.; Merchan, J. R.
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation
FRONTIERS IN ONCOLOGY
IF3.3
2023-08-222
OAAI
Kim, Seok Jin; Jo, Jae-Cheol; Yoon, Dok Hyun; Yang, Deok-Hwan; Yoon, Sang Eun; Lee, Gyeong-Won; Kong, Jee Hyun; Park, Yong; Kang, Ka-Won; Lee, Ho-Sup; Oh, Sung Yong; Shin, Ho-Jin; Lee, Won Sik; Choi, Yoon Seok; Jeong, Seong Hyun; Kim, Min Kyoung; Kang, Hye Jin; Yi, Jun Ho; Lim, Sung-Nam; Yhim, Ho-Young; Do, Young Rok; Yun, Hwan Jung; Eom, Hyeon-Seok; Lee, Mark Hong; Suh, Cheolwon; Kim, Won Seog
Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia
LANCET REGIONAL HEALTH-WESTERN PACIFIC
IF8.1
2021-05-0147
OAAI
Yoon, Sang Eun; Song, Yuqin; Kim, Seok Jin; Yoon, Dok Hyun; Chen, Tsai-Yun; Koh, Youngil; Kang, Ka Won; Lee, Ho Sup; Tay, Kevin Kuang Wei; Lim, Soon Thye; Poon, Michele; Irawan, Cosphiadi; Zhao, Weili; Do, Young Rok; Lee, Mark Hong; Ng, Soo Chin; Lee, Won-Sik; Guo, Ye; Zhang, Huilai; Kang, Hye Jin; Yun, Hwan Jung; Kim, Hyo Jung; Lung, Daryl Tan Chen; Kwak, Jae-Yong; Han, Jae Joon; Mun, Yeung-Chul; Oh, Sung Yong; Shim, Hyeok; Kwon, Jung Hye; Sohn, Byeong Seok; Park, Seong Kyu; Jo, Jae-Cheol; Ko, Young Hyeh; Jun, Zhu; Kim, Won Seog

研究方向

暂未获取到该数据
C
Cheolwon Suh
H 指数:50论文数:615被引数:1.3万
W
Won Seog Kim
H 指数:65论文数:770被引数:2.0万
S
Seok Jin Kim
H 指数:55论文数:694被引数:1.4万
J
Jin Seok Kim
H 指数:54论文数:784被引数:1.2万
D
Dok Hyun Yoon
H 指数:44论文数:525被引数:7,361
J
Jung Hun Kang
H 指数:39论文数:270被引数:6,121
G
Gyeong‐Won Lee
H 指数:39论文数:285被引数:8,426
I
In Gyu Hwang
H 指数:32论文数:207被引数:4,235
Y
Young Rok
H 指数:29论文数:290被引数:3,777
H
Hye Jin Kang
H 指数:32论文数:206被引数:2,921